tiprankstipranks
Profound Medical (PROF)
NASDAQ:PROF
US Market
PROF
Profound Medical
RESEARCH TOOLSreports

Profound Medical (PROF) Ratios

80 Followers

Profound Medical Ratios

PROF's free cash flow for Q2 2026 was C$0.78. For the 2026 fiscal year, PROF's free cash flow was decreased by C$ and operating cash flow was C$-4.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.46 12.52 10.52 6.58 14.82
Quick Ratio
 5.31 11.17 9.64 5.48 12.92
Cash Ratio
 4.20 9.83 8.36 4.12 11.12
Solvency Ratio
 -2.54 -0.58 -2.74 -2.17 -2.14
Operating Cash Flow Ratio
 -3.91 -6.41 -3.57 -3.50 -6.16
Short-Term Operating Cash Flow Coverage
 -7.71 -182.85 -13.50 -10.60 -49.33
Net Current Asset Value
C$ 46.21M$ 1.65M$ 59.25M$ 29.16M$ 49.61M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.03 0.07 0.18 0.13
Debt-to-Equity Ratio
 0.15 0.07 0.08 0.25 0.16
Debt-to-Capital Ratio
 0.13 0.07 0.08 0.20 0.14
Long-Term Debt-to-Capital Ratio
 0.00 0.06 0.05 0.14 0.16
Financial Leverage Ratio
 1.25 2.12 1.16 1.41 1.24
Debt Service Coverage Ratio
 -7.29 -195.96 -18.49 -9.35 -50.10
Interest Coverage Ratio
 0.00 0.00 0.00 -37.16 -170.13
Debt to Market Cap
 0.02 0.02 0.03 0.03 0.04
Interest Debt Per Share
 0.20 0.16 0.21 0.41 0.40
Net Debt to EBITDA
 0.92 1.33 1.55 0.68 1.11
Profitability Margins
Gross Profit Margin
71.73%70.77%65.89%60.87%45.22%
EBIT Margin
-178.84%-256.27%-309.57%-387.93%-422.21%
EBITDA Margin
-176.27%-252.79%-300.81%-375.02%-518.40%
Operating Profit Margin
-184.35%-256.27%-309.57%-397.50%-443.08%
Pretax Profit Margin
-169.74%-262.88%-260.47%-398.62%-424.82%
Net Profit Margin
-170.92%-264.44%-260.45%-396.85%-429.11%
Continuous Operations Profit Margin
-170.92%-264.44%-260.45%-396.85%-429.11%
Net Income Per EBT
100.70%100.60%99.99%99.55%101.01%
EBT Per EBIT
92.08%102.58%84.14%100.28%95.88%
Return on Assets (ROA)
-52.05%-30.80%-39.60%-65.06%-44.50%
Return on Equity (ROE)
-62.45%-65.32%-46.04%-91.63%-55.13%
Return on Capital Employed (ROCE)
-65.74%-31.20%-51.93%-76.22%-49.14%
Return on Invested Capital (ROIC)
-60.49%-31.10%-50.35%-71.39%-48.53%
Return on Tangible Assets
-52.15%-30.83%-39.75%-65.80%-44.98%
Earnings Yield
-13.45%-18.27%-14.96%-12.15%-9.53%
Efficiency Ratios
Receivables Turnover
 1.98 3.12 1.52 0.99 1.05
Payables Turnover
 5.62 3.07 2.77 3.26 1.80
Inventory Turnover
 0.51 0.58 0.63 0.40 0.46
Fixed Asset Turnover
 5.72 18.61 13.01 4.72 3.89
Asset Turnover
 0.30 0.12 0.15 0.16 0.10
Working Capital Turnover Ratio
 0.35 0.25 0.22 0.15 0.10
Cash Conversion Cycle
 830.40 624.83 690.03 1.16K 935.77
Days of Sales Outstanding
 184.70 116.83 240.77 369.51 346.59
Days of Inventory Outstanding
 710.60 626.94 581.21 905.57 791.93
Days of Payables Outstanding
 64.90 118.95 131.95 112.08 202.74
Operating Cycle
 895.31 743.78 821.98 1.28K 1.14K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.98 -1.29 -0.95 -1.05 -1.24
Free Cash Flow Per Share
 -0.98 -1.29 -0.95 -1.05 -1.24
CapEx Per Share
 <0.01 <0.01 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.01 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -198.85 -217.08 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -198.85 -217.08 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -4.83 -8.27 -4.58 -2.83 -3.13
Operating Cash Flow to Sales Ratio
 -1.88 -2.37 -2.20 -3.10 -3.86
Free Cash Flow Yield
-14.85%-16.47%-12.62%-9.48%-8.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -6.84 -5.48 -6.70 -8.23 -10.49
Price-to-Sales (P/S) Ratio
 12.70 14.48 17.41 32.66 45.03
Price-to-Book (P/B) Ratio
 4.85 3.58 3.08 7.54 5.78
Price-to-Free Cash Flow (P/FCF) Ratio
 -6.73 -6.07 -7.93 -10.55 -11.66
Price-to-Operating Cash Flow Ratio
 -6.77 -6.10 -7.93 -10.55 -11.66
Price-to-Earnings Growth (PEG) Ratio
 -0.17 -0.20 0.39 3.79 1.31
Price-to-Fair Value
 4.85 3.58 3.08 7.54 5.78
Enterprise Value Multiple
 -6.28 -4.40 -4.24 -8.03 -7.58
Enterprise Value
 210.10M 182.20M 136.11M 216.78M 262.53M
EV to EBITDA
 -6.28 -4.40 -4.24 -8.03 -7.58
EV to Sales
 11.08 11.12 12.74 30.11 39.29
EV to Free Cash Flow
 -5.87 -4.67 -5.80 -9.72 -10.18
EV to Operating Cash Flow
 -5.90 -4.69 -5.80 -9.72 -10.18
Tangible Book Value Per Share
 1.36 2.19 2.43 1.45 2.47
Shareholders’ Equity Per Share
 1.37 2.19 2.44 1.47 2.50
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 <0.01 <0.01 -0.01
Revenue Per Share
 0.52 0.54 0.43 0.34 0.32
Net Income Per Share
 -0.89 -1.43 -1.12 -1.35 -1.38
Tax Burden
 1.01 1.01 1.00 1.00 1.01
Interest Burden
 0.95 1.03 0.84 1.03 1.01
Research & Development to Revenue
 1.07 1.28 1.59 2.00 2.20
SG&A to Revenue
 1.49 1.99 2.17 1.27 1.42
Stock-Based Compensation to Revenue
 0.22 0.34 0.24 0.47 0.63
Income Quality
 1.10 0.91 0.84 0.79 0.90